Straumann Holding AG/€STMN
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Straumann Holding AG
Straumann Holding AG is a global company specializing in the manufacture and supply of dental implants, orthodontic products, and digital dentistry tools. Headquartered in Basel, Switzerland, the company's products include dental implants, prosthetics, digital equipment, and biomaterials, serving both dental professionals and patients worldwide. Straumann has grown through strategic acquisitions, expanding its footprint in digital and orthodontic technologies. The company operates in various international markets, leveraging a strong focus on innovation and partnerships to maintain its competitive advantage in the dental industry. Its strategic positioning is supported by a commitment to research and development, ensuring continuous advancements in dental solutions.
- Ticker
- €STMN
- Sector
- Health
- Primary listing
- XGAT
- Employees
- 11,582
- Headquarters
- Basel, Switzerland
- Website
- www.straumann.com
STMN Metrics
BasicAdvanced
€18B
46.14
€2.50
1.38
€1.09
0.94%
Price and volume
Market cap
€18B
Beta
1.38
52-week high
€118.60
52-week low
€79.62
Average daily volume
413K
Dividend rate
€1.09
Financial strength
Current ratio
2.264
Quick ratio
1.607
Long term debt to equity
0.208
Total debt to equity
0.208
Dividend payout ratio (TTM)
42.96%
Interest coverage (TTM)
20.72%
Profitability
EBITDA (TTM)
813.286
Gross margin (TTM)
69.26%
Net profit margin (TTM)
14.00%
Operating margin (TTM)
24.70%
Effective tax rate (TTM)
22.14%
Revenue per employee (TTM)
€249,200
Management effectiveness
Return on assets (TTM)
10.99%
Return on equity (TTM)
17.05%
Valuation
Price to earnings (TTM)
46.142
Price to revenue (TTM)
6.436
Price to book
7.43
Price to tangible book (TTM)
12.1
Price to free cash flow (TTM)
50.109
Free cash flow yield (TTM)
2.00%
Free cash flow per share (TTM)
2.304
Dividend yield (TTM)
0.94%
Forward dividend yield
0.94%
Growth
Revenue change (TTM)
2.24%
Earnings per share change (TTM)
-6.64%
3-year revenue growth (CAGR)
4.87%
10-year revenue growth (CAGR)
11.84%
3-year earnings per share growth (CAGR)
-0.56%
10-year earnings per share growth (CAGR)
6.10%
3-year dividend per share growth (CAGR)
7.72%
10-year dividend per share growth (CAGR)
9.60%
What the Analysts think about STMN
Analyst ratings (Buy, Hold, Sell) for Straumann Holding AG stock.
Analyst projections of the future price of Straumann Holding AG stock.
Bulls say / Bears say
Third-quarter organic growth accelerated to 9.2%, beating consensus, with double-digit growth in EMEA and Asia-Pacific and China returning to growth. This broad-based momentum supports the case that Straumann is continuing to gain share across its main markets. (Reuters, Straumann Group)
New implant and digital workflows could help Straumann keep winning customers. The company says iEXCEL is gaining share and its new F.A.S.T. treatment solutions and SIRIOS APS scanning technology are intended to make procedures more efficient for clinics. (Straumann Group, Investing.com)
Improving efficiency is supporting stronger margins: Straumann reported a 26.9% first-half core EBIT margin at constant exchange rates and raised its 2026 margin-expansion target to 140–170 basis points. Higher free cash flow and manufacturing savings add support to this earnings-growth case. (EQS News, EQS News)
China remains a source of uncertainty: the next volume-based procurement round has not yet set its rules, and it could put pressure on implant prices when it is implemented. A reversal in the recent recovery could also unsettle sales expectations. (Reuters, Straumann Group)
Demand for dental procedures remains exposed to consumer caution. Management said high interest rates are weighing on North American patient demand, while purchasing by large dental groups slowed in Brazil, leaving room for growth to fall short of expectations. (Reuters, Straumann Group)
Currency movements may blunt reported growth and profitability: management estimated that end-September exchange rates would reduce full-year revenue by about 2% and core EBIT margin by 70–80 basis points. The impact could change again if exchange rates move before year-end. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 4 Nov 2026.
STMN Financial Performance
Revenues and expenses
STMN Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.